PSURs

For active pharmaceutical ingredients that will continue to require Periodic Safety Update Reports (PSURs) in the future, Diapharm prepares up-to-date, substance-specific PSURs.

Diapharm analyzes company-specific data individually and prepares a submission-ready individual PSUR – for both human and veterinary medicinal products.

PSURs

For active pharmaceutical ingredients that will continue to require Periodic Safety Update Reports (PSURs) in the future, Diapharm prepares up-to-date, substance-specific PSURs.

Custom PSUR Preparation by Diapharm

  • Regular literature reviews
  • Assessment, evaluation, and processing of suspected adverse drug reactions (ADRs)
  • Analysis of company-specific data
  • Monitoring submission deadlines according to authorization documents, the Union Reference Dates (EURD) list, and PSUR Work Sharing and Synchronisation Listss
  • Preparing the final, submission-ready Periodic Safety Update Report (PSUR)

The requirements for PSURs are defined in the European Guideline on Good Pharmacovigilance Practice (GVP), which is based on the international ICH Guideline E2C for Periodic Benefit-Risk Evaluation Reports (PBRERs). Diapharm’s PSURs fully comply with these standards.

 

PSURs available on request

For numerous active pharmaceutical ingredients, Periodic Safety Update Reports (PSURs) are already available.

 


 

Herr Dr. Middeler

Our expertise

All topics related to medicinal products

Taking Responsibility

Regulatory Affairs

Development and Licensing

Investigational Medicinal Products (IMPs)

Quality Management (GxP)

Scientific Information

Pharmacovigilance